Analysis shows antibiotic resistance affecting empirical therapy for UTIs in patients, indicating a need for monitoring.
Background: Trimethoprim-sulfamethoxazole (SXT) is widely used for Pneumocystis pneumonia prophylaxis. However, prolonged use may induce antimicrobial resistance, potentially compromising empirical therapy for urinary tract infections (UTIs).
No takes yet. Share an insight, caveat, or question.
Sugiyama et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: